Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
- 1 February 1997
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 3 (2) , 171-176
- https://doi.org/10.1038/nm0297-171
Abstract
Acquisition of invasive/metastatic potential is a key event in tumor progression. Cell surface glycoproteins and their respective matrix ligands have been implicated in this process. Recent evidence reveals that the secreted glycoprotein SPARC (secreted protein, acidic and rich in cysteine) is highly expressed in different malignant tissues. The present study reports that the suppression of SPARC expression by human melanoma cells using a SPARC antisense expression vector results in a significant decrease in the in vitro adhesive and invasive capacities of tumor cells, completely abolishing their in vivo tumorigenicity. This is the first evidence that SPARC plays a key role in human melanoma invasive-metastatic phenotype development.Keywords
This publication has 31 references indexed in Scilit:
- Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrixImmunology Today, 1996
- Changes in Calcium and Collagen IV Binding Caused by Mutations in the EF Hand and Other Domains of Extracellular Matrix Protein BM-40 (SPARC, Osteonectin)Journal of Molecular Biology, 1994
- Osteonectin/SPARC Regulates Cellular Secretion Rates of Fibronectin and Laminin Extracellular Matrix ProteinsBiochemical and Biophysical Research Communications, 1994
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell and Developmental Biology, 1993
- High‐affinity and low‐affinity calcium binding and stability of the multidomain extracellular 40‐kDa basement membrane glycoprotein (BM‐40/SPARC/osteonectin)European Journal of Biochemistry, 1992
- Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cellsExperimental Cell Research, 1992
- Latent fibronectin‐degrading serine proteinase activity in N‐terminal heparin‐binding domain of human plasma fibronectinEuropean Journal of Biochemistry, 1991
- Properties Of The Novel Proinflammatory Supergene Intercrine Cytokine FamilyAnnual Review of Immunology, 1991
- Modulation of the Metastatic Activity of Melanoma Cells by Laminin and FibronectinScience, 1984